ANVISA: MD studies no more required [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2022-07-13 17:03 (30 d 20:42 ago) – Posting: # 23144
Views: 649

Hi Shuanghe,

» I remember that you had given some talks about BE to ANVISA staff before.

Twice – dealing with the necessity of multiple dose studies.
Haha, now I can write it esp. for you: See this article. If you are short in time, go straight to its Postscript.
Even shorter executive summary (for the guy in the Armani suit): Multiple dose studies are no more required for the ANVISA.
In April 2021 a revision of the guideline was promised for the next summer. If there is one, I failed to find it at the ANVISA’s website, as usual.

» Maybe next time you can suggest why they should not request schedule time point :lol3:

Sure. :-D

Dif-tor heh smusma 🖖 [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,301 posts in 4,667 threads, 1,585 registered users;
online 9 (0 registered, 9 guests [including 5 identified bots]).
Forum time: Saturday 13:46 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5